54 Relationship between rate of percent predicted FEV1 (ppFEV1) decline and baseline and acute change in ppFEV1 in patients (pts) with cystic fibrosis (CF) treated with lumacaftor/ivacaftor (LUM/IVA)
Autor: | Konstan, M.W., McKone, E.F., Moss, R.B., Lubarsky, B., Rubin, J., Millar, S.J., Pasta, D.J., Mayer-Hamblett, N., Goss, C.H., Morgan, W., Sawicki, G.S. |
---|---|
Zdroj: | In Journal of Cystic Fibrosis June 2017 16 Supplement 1:S78-S78 |
Databáze: | ScienceDirect |
Externí odkaz: |